Search Results 21-30 of 27737 for TNF
... Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite ...
Interleukin-17 (IL-17) inhibitors include secukinumab (Cosentyx) and ixekizumab (Taltz). Tumor necrosis factor (TNF) inhibitors include etanercept (Enbrel), ...
Many cytokines and chemokines are known to be highly upregulated in AH , of which tumor necrosis factor-alpha (TNF-alpha) is a prototypical example. TNF ...
... TNF inhibitors. They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the balancing acts of medicine, the anti ...
A Trial of Tumor Necrosis Factor Alpha and Interleukin-2 Coding Oncolytic Adenovirus (TILT-123) Combined with Pembrolizumab to Treat Refractory Ovarian Cancer.
... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of refractory or intolerance to CS and/or IS may have been previously exposed to anti ...
TNF-alpha inhibitors: Tumor necrosis factor (TNF)-alpha is a protein made by the white blood cells that activates the immune system. TNF-alpha inhibitors ...
"For the last 25 years, tumor necrosis factor has been an important therapeutic target to treat autoimmune disease and tissue inflammation," says Mayo Clinic ...
New medications. The immunology of IBD is very complex, and drug targeting is complex. Within the United States, four anti-TNF agents are currently approved for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!